WO2009005076A1 - アミド化合物 - Google Patents
アミド化合物 Download PDFInfo
- Publication number
- WO2009005076A1 WO2009005076A1 PCT/JP2008/061943 JP2008061943W WO2009005076A1 WO 2009005076 A1 WO2009005076 A1 WO 2009005076A1 JP 2008061943 W JP2008061943 W JP 2008061943W WO 2009005076 A1 WO2009005076 A1 WO 2009005076A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptors
- antagonistic activities
- compounds
- renal failure
- diabetic nephropathy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009521644A JP5408434B2 (ja) | 2007-07-03 | 2008-07-02 | アミド化合物 |
CA002692265A CA2692265A1 (en) | 2007-07-03 | 2008-07-02 | Amide compounds |
EP08790794A EP2172447A4 (en) | 2007-07-03 | 2008-07-02 | amide |
US12/667,492 US20110028463A1 (en) | 2007-07-03 | 2008-07-02 | Amide compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007174733 | 2007-07-03 | ||
JP2007-174733 | 2007-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009005076A1 true WO2009005076A1 (ja) | 2009-01-08 |
Family
ID=40226119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/061943 WO2009005076A1 (ja) | 2007-07-03 | 2008-07-02 | アミド化合物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20110028463A1 (ja) |
EP (2) | EP2172447A4 (ja) |
JP (1) | JP5408434B2 (ja) |
CA (1) | CA2692265A1 (ja) |
WO (1) | WO2009005076A1 (ja) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009139373A1 (ja) | 2008-05-14 | 2009-11-19 | アステラス製薬株式会社 | アミド化合物 |
EP2320906A1 (en) * | 2008-08-14 | 2011-05-18 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as ep4 receptor antagonists |
US8283465B2 (en) | 2009-07-17 | 2012-10-09 | Japan Tobacco Inc. | Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
US20130184463A1 (en) * | 2011-12-21 | 2013-07-18 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
JP2013536210A (ja) * | 2010-08-27 | 2013-09-19 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Kcnq2/3調節因子としての置換された2−オキシ−キノリン−3−カルボキサミド |
JP2013538825A (ja) * | 2010-09-21 | 2013-10-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬組成物 |
WO2014200075A1 (ja) | 2013-06-12 | 2014-12-18 | 科研製薬株式会社 | 4-アルキニルイミダゾール誘導体およびそれを有効成分として含有する医薬 |
WO2015147020A1 (ja) * | 2014-03-26 | 2015-10-01 | アステラス製薬株式会社 | アミド化合物 |
JP2016540007A (ja) * | 2013-12-17 | 2016-12-22 | イーライ リリー アンド カンパニー | フェノキシエチル環状アミン誘導体およびep4受容体モジュレーターとしてのその活性 |
JP2017500309A (ja) * | 2013-12-17 | 2017-01-05 | イーライ リリー アンド カンパニー | ジメチル安息香酸化合物 |
WO2017122754A1 (ja) | 2016-01-12 | 2017-07-20 | 日本ケミファ株式会社 | 電位依存性t型カルシウムチャネル阻害剤 |
JP2018527295A (ja) * | 2015-07-23 | 2018-09-20 | 武田薬品工業株式会社 | 複素環化合物 |
WO2018210995A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | N-substituted indole derivatives |
JP2020196731A (ja) * | 2013-09-27 | 2020-12-10 | アラーガン、インコーポレイテッドAllergan,Incorporated | 皮膚修復のための化合物及び方法 |
JP2021514939A (ja) * | 2018-03-02 | 2021-06-17 | シェンチェン イオノヴァ ライフ サイエンス カンパニー リミテッドShenzhen Ionova Life Science Co., Ltd. | ヘテロ二環式有機酸およびその塩類 |
JP2021521128A (ja) * | 2018-04-17 | 2021-08-26 | テンペスト セラピューティクス,インク. | 二環式カルボキサミドおよびその使用方法 |
US11241431B2 (en) | 2015-11-20 | 2022-02-08 | Idorsia Pharmaceuticals Ltd | N-substituted indole derivatives as PGE2 receptor modulators |
JP2022522993A (ja) * | 2019-01-22 | 2022-04-21 | キーセラ・(スーチョウ)・ファーマシューティカルズ・カンパニー・リミテッド | Pge2/ep4シグナル伝達を阻害する化合物、その製造方法及びその医薬における応用 |
US11325899B2 (en) | 2017-05-18 | 2022-05-10 | Idorsia Pharmaceuticals Ltd | Benzofurane and benzothiophene derivatives as PGE2 receptor modulators |
WO2022102731A1 (ja) | 2020-11-13 | 2022-05-19 | 小野薬品工業株式会社 | Ep4拮抗薬と免疫チェックポイント阻害物質との併用によるがん治療 |
US11446298B2 (en) | 2017-05-18 | 2022-09-20 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
WO2023287241A1 (ko) * | 2021-07-15 | 2023-01-19 | 주식회사 휴사이온 | 신규한 벤즈옥사졸아민 유도체 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물 |
US11712438B2 (en) | 2017-05-18 | 2023-08-01 | Idorsia Pharmaceuticals Ltd | Phenyl derivatives as PGE2 receptor modulators |
US11839613B2 (en) | 2017-05-18 | 2023-12-12 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives as PGE2 receptor modulators |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
EP2765128A1 (en) * | 2013-02-07 | 2014-08-13 | Almirall, S.A. | Substituted benzamides with activity towards EP4 receptors |
TW201607943A (zh) | 2013-12-19 | 2016-03-01 | 拜耳製藥公司 | 作為ep4配體之新穎苯并咪唑衍生物 |
WO2018162562A1 (en) | 2017-03-10 | 2018-09-13 | Bayer Pharma Aktiengesellschaft | Use of an ep4 antagonist for the treatment of inflammatory pain |
US11066405B2 (en) | 2017-04-18 | 2021-07-20 | Tempest Therapeutics, Inc. | Bicyclic compounds and their use in the treatment of cancer |
CN110891935B (zh) | 2017-04-18 | 2023-12-01 | 泰普斯特医疗公司 | 双环化合物及其在癌症治疗中的用途 |
WO2019038156A1 (en) | 2017-08-22 | 2019-02-28 | Bayer Pharma Aktiengesellschaft | USE OF AN EP4 ANTAGONIST FOR THE TREATMENT OF ARTHRITIS |
CN109836434B (zh) * | 2017-11-27 | 2020-09-25 | 上海宇耀生物科技有限公司 | 噻吩并环类化合物及其合成方法和应用 |
US20220324803A1 (en) * | 2019-06-11 | 2022-10-13 | Teon Therapeutics, Inc. | Prostaglandin e2 receptor 4 antagonists and uses thereof |
US20240109887A1 (en) * | 2021-03-02 | 2024-04-04 | Viva Star Biosciences (Suzhou) Co., Ltd. | Novel substituted bicyclic aza-heterocycles as sos1 inhibitors |
CA3224971A1 (en) | 2021-08-03 | 2023-02-09 | Denise Andersen | Process for preparing aficamten |
WO2023160569A1 (en) * | 2022-02-24 | 2023-08-31 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Carboxamide compounds as pge2 receptor antagonists |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0545790A (ja) * | 1991-08-12 | 1993-02-26 | Konica Corp | 高感度・高鮮鋭性で、かつ処理ムラの少ないハロゲン化銀写真感光材料 |
JP2002501502A (ja) * | 1997-04-25 | 2002-01-15 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害物質 |
JP2002145840A (ja) * | 2000-01-25 | 2002-05-22 | Japan Tobacco Inc | N−アリールヒドラジド化合物及びその医薬用途 |
WO2005021508A1 (en) | 2003-09-03 | 2005-03-10 | Pfizer Inc. | Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
JP2005232149A (ja) * | 2003-03-07 | 2005-09-02 | Santen Pharmaceut Co Ltd | 4−ピリジルアルキルチオ基を置換基として有する新規化合物 |
WO2005105732A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Substituted methyl aryl or heteroaryl amide compounds |
WO2005105733A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Ortho substituted aryl or heteroaryl amide compounds |
WO2007121578A1 (en) | 2006-04-24 | 2007-11-01 | Merck Frosst Canada Ltd. | Indole amide derivatives as ep4 receptor antagonists |
WO2007143825A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Indoline amide derivatives as ep4 receptor ligands |
WO2008101716A2 (de) | 2007-02-23 | 2008-08-28 | Schenck Rotec Gmbh | Verfahren und vorrichtung zur unwuchtmessung von rotoren mit unsymmetrischer massenverteilung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0031315D0 (en) * | 2000-12-21 | 2001-02-07 | Glaxo Group Ltd | Indole derivatives |
TWI422583B (zh) * | 2003-03-07 | 2014-01-11 | 參天製藥股份有限公司 | 具有以4-吡啶烷硫基為取代基之新穎化合物 |
JP5259592B2 (ja) * | 2006-08-11 | 2013-08-07 | メルク カナダ インコーポレイテッド | Ep4受容体リガンドとしてのチオフェンカルボキサミド誘導体 |
NZ577109A (en) * | 2006-12-15 | 2011-12-22 | Glaxo Group Ltd | Benzamide derivatives as ep4 receptor agonists |
-
2008
- 2008-07-02 EP EP08790794A patent/EP2172447A4/en not_active Withdrawn
- 2008-07-02 EP EP12151731A patent/EP2460787A1/en not_active Withdrawn
- 2008-07-02 CA CA002692265A patent/CA2692265A1/en not_active Abandoned
- 2008-07-02 JP JP2009521644A patent/JP5408434B2/ja not_active Expired - Fee Related
- 2008-07-02 US US12/667,492 patent/US20110028463A1/en not_active Abandoned
- 2008-07-02 WO PCT/JP2008/061943 patent/WO2009005076A1/ja active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0545790A (ja) * | 1991-08-12 | 1993-02-26 | Konica Corp | 高感度・高鮮鋭性で、かつ処理ムラの少ないハロゲン化銀写真感光材料 |
JP2002501502A (ja) * | 1997-04-25 | 2002-01-15 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害物質 |
JP2002145840A (ja) * | 2000-01-25 | 2002-05-22 | Japan Tobacco Inc | N−アリールヒドラジド化合物及びその医薬用途 |
JP2005232149A (ja) * | 2003-03-07 | 2005-09-02 | Santen Pharmaceut Co Ltd | 4−ピリジルアルキルチオ基を置換基として有する新規化合物 |
WO2005021508A1 (en) | 2003-09-03 | 2005-03-10 | Pfizer Inc. | Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
JP2007504210A (ja) * | 2003-09-03 | 2007-03-01 | ファイザー株式会社 | プロスタグランジンe2拮抗薬としてのフェニルまたはピリジルアミド化合物 |
WO2005105732A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Substituted methyl aryl or heteroaryl amide compounds |
WO2005105733A1 (en) | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Ortho substituted aryl or heteroaryl amide compounds |
WO2007121578A1 (en) | 2006-04-24 | 2007-11-01 | Merck Frosst Canada Ltd. | Indole amide derivatives as ep4 receptor antagonists |
WO2007143825A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Indoline amide derivatives as ep4 receptor ligands |
WO2008101716A2 (de) | 2007-02-23 | 2008-08-28 | Schenck Rotec Gmbh | Verfahren und vorrichtung zur unwuchtmessung von rotoren mit unsymmetrischer massenverteilung |
Non-Patent Citations (3)
Title |
---|
"Drug Design", vol. 7, 1990, HIROKAWA PUBLISHING COMPANY, article "Pharmaceutical Research and Development", pages: 163 - 198 |
PROG. MED., vol. 5, 1985, pages 2157 - 2161 |
See also references of EP2172447A4 * |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5375824B2 (ja) * | 2008-05-14 | 2013-12-25 | アステラス製薬株式会社 | アミド化合物 |
EP2277858A4 (en) * | 2008-05-14 | 2012-06-13 | Astellas Pharma Inc | AMIDE COMPOUND |
AU2009247262B2 (en) * | 2008-05-14 | 2013-01-31 | Astellas Pharma Inc. | Amide compound |
EP2565191A1 (en) * | 2008-05-14 | 2013-03-06 | Astellas Pharma Inc. | 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy |
WO2009139373A1 (ja) | 2008-05-14 | 2009-11-19 | アステラス製薬株式会社 | アミド化合物 |
US8598355B2 (en) | 2008-05-14 | 2013-12-03 | Astellas Pharma Inc. | Amide compound |
EP2320906A1 (en) * | 2008-08-14 | 2011-05-18 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as ep4 receptor antagonists |
EP2320906A4 (en) * | 2008-08-14 | 2012-05-09 | Beta Pharma Canada Inc | HETEROCYCLIC AMIDE DERIVATIVES AS AN EP4 RECEPTOR ANTAGONISTS |
US8404736B2 (en) | 2008-08-14 | 2013-03-26 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as EP4 receptor antagonists |
US8283465B2 (en) | 2009-07-17 | 2012-10-09 | Japan Tobacco Inc. | Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
JP2013536210A (ja) * | 2010-08-27 | 2013-09-19 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Kcnq2/3調節因子としての置換された2−オキシ−キノリン−3−カルボキサミド |
JP2013538825A (ja) * | 2010-09-21 | 2013-10-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬組成物 |
JP2015500882A (ja) * | 2011-12-21 | 2015-01-08 | アラーガン インコーポレイテッドAllergan,Incorporated | 一般的な抗炎症反応を与える複数のプロスタグランジン受容体において作用する化合物 |
US10988474B2 (en) | 2011-12-21 | 2021-04-27 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
US10392382B2 (en) | 2011-12-21 | 2019-08-27 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
US20130184463A1 (en) * | 2011-12-21 | 2013-07-18 | Allergan, Inc. | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
US9855257B2 (en) | 2013-06-12 | 2018-01-02 | Kaken Pharmaceutical Co., Ltd. | 4-alkynyl imidazole derivative and medicine comprising same as active ingredient |
KR20160018745A (ko) | 2013-06-12 | 2016-02-17 | 가껭세이야꾸가부시기가이샤 | 4-알키닐이미다졸 유도체 및 그것을 유효 성분으로서 함유하는 의약 |
US9593081B2 (en) | 2013-06-12 | 2017-03-14 | Kaken Pharmaceutical Co., Ltd. | 4-alkynyl imidazole derivative and medicine comprising same as active ingredient |
WO2014200075A1 (ja) | 2013-06-12 | 2014-12-18 | 科研製薬株式会社 | 4-アルキニルイミダゾール誘導体およびそれを有効成分として含有する医薬 |
JP2020196731A (ja) * | 2013-09-27 | 2020-12-10 | アラーガン、インコーポレイテッドAllergan,Incorporated | 皮膚修復のための化合物及び方法 |
JP2016540007A (ja) * | 2013-12-17 | 2016-12-22 | イーライ リリー アンド カンパニー | フェノキシエチル環状アミン誘導体およびep4受容体モジュレーターとしてのその活性 |
JP2017500309A (ja) * | 2013-12-17 | 2017-01-05 | イーライ リリー アンド カンパニー | ジメチル安息香酸化合物 |
JPWO2015147020A1 (ja) * | 2014-03-26 | 2017-04-13 | アステラス製薬株式会社 | アミド化合物 |
US10106523B2 (en) | 2014-03-26 | 2018-10-23 | Astellas Pharma Inc. | Amide compound |
KR20160138098A (ko) | 2014-03-26 | 2016-12-02 | 아스테라스 세이야쿠 가부시키가이샤 | 아미드 화합물 |
WO2015147020A1 (ja) * | 2014-03-26 | 2015-10-01 | アステラス製薬株式会社 | アミド化合物 |
JP2018527295A (ja) * | 2015-07-23 | 2018-09-20 | 武田薬品工業株式会社 | 複素環化合物 |
US12011444B2 (en) | 2015-11-20 | 2024-06-18 | Idorsia Pharmaceuticals Ltd | N-substituted indole derivatives as PGE2 receptor modulators |
US11241431B2 (en) | 2015-11-20 | 2022-02-08 | Idorsia Pharmaceuticals Ltd | N-substituted indole derivatives as PGE2 receptor modulators |
WO2017122754A1 (ja) | 2016-01-12 | 2017-07-20 | 日本ケミファ株式会社 | 電位依存性t型カルシウムチャネル阻害剤 |
US11446298B2 (en) | 2017-05-18 | 2022-09-20 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
US11712438B2 (en) | 2017-05-18 | 2023-08-01 | Idorsia Pharmaceuticals Ltd | Phenyl derivatives as PGE2 receptor modulators |
WO2018210995A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | N-substituted indole derivatives |
US11325899B2 (en) | 2017-05-18 | 2022-05-10 | Idorsia Pharmaceuticals Ltd | Benzofurane and benzothiophene derivatives as PGE2 receptor modulators |
US11839613B2 (en) | 2017-05-18 | 2023-12-12 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives as PGE2 receptor modulators |
JP2022120130A (ja) * | 2018-03-02 | 2022-08-17 | シェンチェン イオノヴァ ライフ サイエンス カンパニー リミテッド | ヘテロ二環式有機酸およびその塩類 |
JP2021514939A (ja) * | 2018-03-02 | 2021-06-17 | シェンチェン イオノヴァ ライフ サイエンス カンパニー リミテッドShenzhen Ionova Life Science Co., Ltd. | ヘテロ二環式有機酸およびその塩類 |
JP2021521128A (ja) * | 2018-04-17 | 2021-08-26 | テンペスト セラピューティクス,インク. | 二環式カルボキサミドおよびその使用方法 |
US11795156B2 (en) | 2018-04-17 | 2023-10-24 | Tempest Therapeutics, Inc. | Bicyclic carboxamides and methods of use thereof |
JP7361713B2 (ja) | 2018-04-17 | 2023-10-16 | テンペスト セラピューティクス,インク. | 二環式カルボキサミドおよびその使用方法 |
JP7488269B2 (ja) | 2019-01-22 | 2024-05-21 | キーセラ・(スーチョウ)・ファーマシューティカルズ・カンパニー・リミテッド | Pge2/ep4シグナル伝達を阻害する化合物、その製造方法及びその医薬における応用 |
JP2022522993A (ja) * | 2019-01-22 | 2022-04-21 | キーセラ・(スーチョウ)・ファーマシューティカルズ・カンパニー・リミテッド | Pge2/ep4シグナル伝達を阻害する化合物、その製造方法及びその医薬における応用 |
WO2022102731A1 (ja) | 2020-11-13 | 2022-05-19 | 小野薬品工業株式会社 | Ep4拮抗薬と免疫チェックポイント阻害物質との併用によるがん治療 |
WO2023287241A1 (ko) * | 2021-07-15 | 2023-01-19 | 주식회사 휴사이온 | 신규한 벤즈옥사졸아민 유도체 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물 |
Also Published As
Publication number | Publication date |
---|---|
EP2172447A4 (en) | 2011-08-24 |
EP2172447A1 (en) | 2010-04-07 |
CA2692265A1 (en) | 2009-01-08 |
EP2460787A1 (en) | 2012-06-06 |
US20110028463A1 (en) | 2011-02-03 |
JP5408434B2 (ja) | 2014-02-05 |
JPWO2009005076A1 (ja) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009005076A1 (ja) | アミド化合物 | |
WO2007086001A3 (en) | Novel pyridine derivatives | |
WO2008034736A3 (en) | Oxindole derivatives as anticancer agents | |
DK2137184T3 (da) | Imidazo[1,2-a]pyridinforbindelser som receptor-tyrosinkinaseinhibitorer | |
WO2009042114A3 (en) | Phenazine derivatives and uses thereof | |
EP2631235A3 (en) | Pest control agent | |
DK2201012T3 (da) | Pyrrolo[2,3-d]pyrimidinderivater som proteinkinase b-hæmmere | |
MY154909A (en) | Novel thiophene derivatives | |
DK2057154T3 (da) | PYRIDO-(2,3-B)pyrazinderivater, der er anvendelige som herbicidale forbindelser | |
GT200900014A (es) | Derivados de i-(-d-glucopiranosil)-3-(4-ciclopropilfenilmetil)-4-halogeno indoly uso de los mismos como inhibidores de los transportadores de glucosa dependientes de sodio. | |
DK2197844T3 (da) | Spiroheterocykliske pyrrolidindionderivater, der er anvendelige som pesticider | |
DK1904494T3 (da) | Imidazo[1,2-A]pyridin-forbindelser som VEGF-R2-inhibitorer | |
HK1167397A1 (zh) | 作為抗癌症劑的 -取代的喹唑酮衍生物 | |
AU2006253863A8 (en) | Novel Heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors | |
DK2350075T3 (da) | Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer | |
WO2007148185A3 (en) | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | |
WO2007149907A3 (en) | Pyrazoloquinazolinones as parp inhibitors | |
DK2029549T3 (da) | Phenyl-pyrazol-derivater som ikke-steroide glucocoricoid-receptorligander | |
WO2007149829A3 (en) | Therapeutic compounds | |
HK1102597A1 (en) | 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors | |
WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
WO2006134499A3 (en) | 2-(1h-indolylsulfanyl)-aryl amine derivatives | |
WO2008068299A3 (en) | Hydrobromide salt of an anti-hiv compound | |
WO2007143456A3 (en) | Benzimidazol substituted thiophene derivatives with activity on plk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08790794 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009521644 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2692265 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008790794 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12667492 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |